The DOI matches its Crossref record; 18 of the 18 references it cites were found in a registry or an index.
Acylcarnitines: potential implications for skeletal muscle insulin resistance
Open accessAbstract
Insulin resistance may be linked to incomplete fatty acid β‐oxidation and the subsequent increase in acylcarnitine species in different tissues including skeletal muscle. It is not known if acylcarnitines participate in muscle insulin resistance or simply reflect dysregulated metabolism. The aims of this study were to determine whether acylcarnitines can elicit muscle insulin resistance and to better understand the link between incomplete muscle fatty acid β‐oxidation, oxidative stress, inflammation, and insulin‐resistance development. Differentiated C2C12, primary mouse, and human myotubes were treated with acylcarnitines (C4:0, C14:0, C16:0) or with palmitate with or without carnitine acyltransferase inhibition by mildronate. Treatment with C4:0, C14:0, and C16:0 acylcarnitines resulted in 20–30% decrease in insulin response at the level of Akt phosphorylation and/or glucose uptake. Mildronate reversed palmitate‐induced insulin resistance concomitant with an ~25% decrease in short‐chain acylcarnitine and acetylcarnitine secretion. Although proinflammatory cytokines were not affected under these conditions, oxidative stress was increased by 2–3 times by short‐ or long‐chain acylcarnitines. Acylcarnitine‐induced oxidative stress and insulin resistance were reversed by treatment with antioxidants. Results are consistent with the conclusion that incomplete muscle fatty acid β‐oxidation causes acylcarnitine accumulation and associated oxidative stress, raising the possibility that these metabolites play a role in muscle insulin resistance.—Aguer, C., McCoin, C. S., Knotts, T. A., Thrush, A. B., Ono‐Moore, K., McPherson, R., Dent, R., Hwang, D. H., Adams, S. H., Harper, M.‐E. Acylcarnitines: potential implications for skeletal muscle insulin resistance. FASEB J. 29, 336–345 (2015). www.fasebj.org
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Reactive oxygen species have a causal role in multiple forms of insulin resistance
Houstis, N., Rosen, E. D., & Lander, E. S. (2006) · Nature · doi:10.1038/nature04634 · Cited by 2,525 · cited 1×
“Studies have concluded that increased oxidative stress causes muscle insulin resistance (6, 42) and that oxidative stress develops in response to lipid overload (7).”
BackgroundImpaired Mitochondrial Activity in the Insulin-Resistant Offspring of Patients with Type 2 Diabetes
Petersen, K. F., Dufour, S., Befroy, D., Garcia, R., & Shulman, G. I. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa031314 · Cited by 2,193
Anderson, E. J., Lustig, M. E., Boyle, K. E., Woodlief, T. L., Kane, D. A., Lin, C.-T., Price, J. W., Kang, L., Rabinovitch, P. S., Szeto, H. H., et al. (2009) · Journal of Clinical Investigation · doi:10.1172/jci37048 · Cited by 1,253 · cited 2×
“Studies have concluded that increased oxidative stress causes muscle insulin resistance (6, 42) and that oxidative stress develops in response to lipid overload (7).”
BackgroundThe sites and topology of mitochondrial superoxide production
Brand, M. D. (2010) · Experimental Gerontology · doi:10.1016/j.exger.2010.01.003 · Cited by 1,217 · cited 1×
“However, it is likely that a greater proportion of reducing equivalents produced from fatty acid b-oxidation enter the electron transport chain at the electron transfer flavoprotein, thus bypassing complex I, the main ROS production site (8, 9).”
BackgroundBonnard, C., Durand, A., Peyrol, S., Chanseaume, E., Chauvin, M.-A., Morio, B., Vidal, H., & Rieusset, J. (2008) · Journal of Clinical Investigation · doi:10.1172/jci32601 · Cited by 819
Newsholme, P., Haber, E. P., Hirabara, S. M., Rebelato, E. L. O., Procopio, J., Morgan, D., Oliveira‐Emilio, H. C., Carpinelli, A. R., & Curi, R. (2007) · The Journal of Physiology · doi:10.1113/jphysiol.2007.135871 · Cited by 684
Chavez, J. A., Knotts, T. A., Wang, L.-P., Li, G., Dobrowsky, R. T., Florant, G. L., & Summers, S. A. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m212307200 · Cited by 617
Self-citationOxidative stress and the etiology of insulin resistance and type 2 diabetes
Henriksen, E. J., Diamond-Stanic, M. K., & Marchionne, E. M. (2011) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2010.12.005 · Cited by 600
Adams, S. H., Hoppel, C. L., Lok, K. H., Zhao, L., Wong, S. W., Minkler, P. E., Hwang, D. H., Newman, J. W., & Garvey, W. T. (2009) · The Journal of Nutrition · doi:10.3945/jn.108.103754 · Cited by 598 · cited 4×
“Based on proof-ofprinciple studies suggesting a proinflammatory activity of mixed stereoisomer DL-medium-chain acylcarnitines (activation of anNF-kB promoter construct), it was hypothesized that these metabolites contribute to insulin resistance (15).”
BackgroundMethodResultSelf-citationMitochondrial respiration is decreased in skeletal muscle of patients with type 2 diabetes
Mogensen, M., Sahlin, K., Fernström, M., Glintborg, D., Vind, B. F., Beck-Nielsen, H., & Højlund, K. (2007) · Diabetes · doi:10.2337/db06-0981 · Cited by 573
Cited by
Mechanisms of Insulin Action and Insulin Resistance
Petersen, M. C., & Shulman, G. I. (2018) · Physiological Reviews · doi:10.1152/physrev.00063.2017 · Cited by 3,028
Metabolomics for Investigating Physiological and Pathophysiological Processes
Wishart, D. S. (2019) · Physiological Reviews · doi:10.1152/physrev.00035.2018 · Cited by 1,212
Metabolites as regulators of insulin sensitivity and metabolism
Yang, Q., Vijayakumar, A., & Kahn, B. B. (2018) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-018-0044-8 · Cited by 663
The Liver as an Endocrine Organ—Linking NAFLD and Insulin Resistance
Watt, M. J., Miotto, P. M., De Nardo, W., & Montgomery, M. K. (2019) · Endocrine Reviews · doi:10.1210/er.2019-00034 · Cited by 615
Acylcarnitines: Nomenclature, Biomarkers, Therapeutic Potential, Drug Targets, and Clinical Trials
Dambrova, M., Makrecka-Kuka, M., Kuka, J., Vilskersts, R., Nordberg, D., Attwood, M. M., Smesny, S., Sen, Z. D., Guo, A. C., Oler, E., et al. (2022) · Pharmacological Reviews · doi:10.1124/pharmrev.121.000408 · Cited by 507
Acylcarnitines—old actors auditioning for new roles in metabolic physiology
McCoin, C. S., Knotts, T. A., & Adams, S. H. (2015) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2015.129 · Cited by 344
Self-citationVanweert, F., Schrauwen, P., & Phielix, E. (2022) · Nutrition & Diabetes · doi:10.1038/s41387-022-00213-3 · Cited by 289
Hunter, W. G., Kelly, J. P., McGarrah, R. W., Khouri, M. G., Craig, D., Haynes, C., Ilkayeva, O., Stevens, R. D., Bain, J. R., Muehlbauer, M. J., et al. (2016) · Journal of the American Heart Association · doi:10.1161/jaha.115.003190 · Cited by 271
Muscle-generated BDNF is a sexually dimorphic myokine that controls metabolic flexibility
Yang, X., Brobst, D., Chan, W. S., Tse, M. C. L., Herlea-Pana, O., Ahuja, P., Bi, X., Zaw, A. M., Kwong, Z. S. W., Jia, W.-H., et al. (2019) · Science Signaling · doi:10.1126/scisignal.aau1468 · Cited by 99
Statins and risk of type 2 diabetes: mechanism and clinical implications
Laakso, M., & Fernandes Silva, L. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1239335 · Cited by 82
Matos, M. A. D., Vieira, D. V., Pinhal, K. C., Lopes, J. F., Dias-Peixoto, M. F., Pauli, J. R., Castro Magalhães, F. D., Little, J. P., Rocha-Vieira, E., & Amorim, F. T. (2018) · Frontiers in Physiology · doi:10.3389/fphys.2018.01451 · Cited by 75
Story behind meldonium–from pharmacology to performance enhancement: a narrative review
Schobersberger, W., Dünnwald, T., Gmeiner, G., & Blank, C. (2017) · British Journal of Sports Medicine · doi:10.1136/bjsports-2016-096357 · Cited by 61
The lifecycle of skeletal muscle mitochondria in obesity
Pileggi, C. A., Parmar, G., & Harper, M. (2021) · Obesity Reviews · doi:10.1111/obr.13164 · Cited by 61
“in vitro studies also demonstrate excess incomplete fatty acid oxidation and the accumulation of toxic acyl carnitines and fatty acid intermediates in primary myotubes from subjects with obesity compared to lean individuals.(64,68) Simply put: TABLE 1 (Continued)”
BackgroundSelf-citationvan den Berg, R., Mook-Kanamori, D. O., Donga, E., van Dijk, M., van Dijk, J. G., Lammers, G.-J., van Kralingen, K. W., Prehn, C., Adamski, J., Romijn, J. A., et al. (2016) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2015.09.017 · Cited by 55
Mitochondrial fat oxidation is essential for lipid-induced inflammation in skeletal muscle in mice
Warfel, J. D., Bermudez, E. M., Mendoza, T. M., Ghosh, S., Zhang, J., Elks, C. M., Mynatt, R., & Vandanmagsar, B. (2016) · Scientific Reports · doi:10.1038/srep37941 · Cited by 50
The Impact of Dysmetabolic Sarcopenia Among Insulin Sensitive Tissues: A Narrative Review
Armandi, A., Rosso, C., Caviglia, G. P., Ribaldone, D. G., & Bugianesi, E. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.716533 · Cited by 48
Mitochondrial function and diabetes: consequences for skeletal and cardiac muscle metabolism
Schrauwen-Hinderling, V. B., Kooi, M. E., & Schrauwen, P. (2016) · Antioxidants & Redox Signaling · doi:10.1089/ars.2015.6291 · Cited by 47
Baker, P. R., Patinkin, Z. W., Shapiro, A. L. B., de la Houssaye, B. A., Janssen, R. C., Vanderlinden, L. A., Dabelea, D., & Friedman, J. E. (2017) · Scientific Reports · doi:10.1038/s41598-017-17588-4 · Cited by 33
The manifold role of the mitochondria in skeletal muscle insulin resistance
Cade, W. T. (2018) · Current Opinion in Clinical Nutrition & Metabolic Care · doi:10.1097/mco.0000000000000480 · Cited by 21
Metadata
- Authors
- Aguer, C., McCoin, C. S., Knotts, T. A., Thrush, A. B., Ono‐Moore, K., McPherson, R., Dent, R., Hwang, D. H., Adams, S. H., & Harper, M.
- Venue
- The FASEB Journal
- Publisher
- Wiley
- Published
- 2014-10-23
- Volume
- 29
- Issue
- 1
- Pages
- 336-345
- ISSN
- 0892-6638 (ISSN-L)
- 1530-6860
- OpenAlex
- W2064612269
- Cited by
- 240
- References
- 18
- FWCI
- 5.84
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.